MONEYMAKER, S.C. – Trademark Portfolio
Entity Type: 03
MONEYMAKER, S.C. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 7 trademarks are registered and 2 are pending. Notable registered marks include Z, RUSH Z, XICO Z, and ZEPPELIN. The owner is based in Benito Juárez.
Av. Insurgentes Sur #605 interior 502
Colonia Nápoles
Benito Juárez 06100 , MX
Showing of trademarks Trademarks
Trademark Classifications
MONEYMAKER, S.C.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does MONEYMAKER, S.C. have?
MONEYMAKER, S.C. has 15 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 pending, 6 abandoned.
What trademark classes does MONEYMAKER, S.C. file in?
MONEYMAKER, S.C. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MONEYMAKER, S.C.'s most well-known trademarks?
MONEYMAKER, S.C.'s registered trademark portfolio includes well-known marks such as Z, RUSH Z, XICO Z, and ZEPPELIN. These are among 7 currently registered trademarks in the portfolio.
What is MONEYMAKER, S.C.'s trademark registration success rate?
MONEYMAKER, S.C. has a 54% trademark registration rate, with 7 out of 13 resolved applications resulting in successful registration. Currently, 2 applications are pending review.